TUNGKOL SA EPISODE NA ITO

Ingles
Estados Unidos

KOPYA NG SALIN 🔗

I-SEARCH ANG MGA NAKARAANG EPISODE

I-search ang mga nakaraang episode ng Taylor & Francis.

IBA PANG MGA EPISOD SA PODCAST NA ITO

First-line management of unresectable hepatocellular carcinoma: clinical perspectives from the CheckMate 9DW study by Taylor & Francis Group
In this interview, discover discuss key findings from the DESTINY-Breast09 trial and their implications for clinical practice, including practical advice for oncologists exploring treatment sequencing strategies with T-DXd.
In this podcast episode, the speakers discuss how the findings from the EMBARK clinical trial could translate into real world practice.
This podcast features two of the investigators from the international, randomized, Phase III EMBARK trial (NCT02319837) in conversation. EMBARK evaluated the efficacy and safety of enzalutamide plus androgen deprivation therapy and enzalutamide monotherapy, as compared with androgen deprivation t…
Paunawa: Ang podcast at artwork na naka-embed sa page na ito ay mula sa Taylor & Francis Group, na pag-aari ng may-ari nito at hindi kaakibat o ineendorso ng Listen Notes, Inc.